InChI=1S/C20H30O4/c1-2-3-4-5-10-13-16-19(24-23)17-14-11-8-6-7-9-12-15-18-20(21)22/h3-4,7-11,13-14,17,19,23H,2,5-6,12,15-16,18H2,1H3,(H,21,22)/p-1/b4-3-,9-7-,11-8-,13-10-,17-14+/t19-/m0/s1 |
HDMYXONNVAOHFR-UOLHMMFFSA-M |
C(=C\C\C=C/C=C/[C@H](C/C=C\C/C=C\CC)OO)\CCCC([O-])=O |
|
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
(via 12-HPEPE(1-) )
|
|
View more via ChEBI Ontology
(5Z,8Z,10E,12S,14Z-17Z)-12-hydroperoxyicosa-5,8,10,14,17-pentaenoate
|
(12S)-hydroperoxy-(5Z,8Z,10E,14Z,17Z)-eicosapentaenoate
|
UniProt
|
(12S)-hydroperoxy-(5Z,8Z,10E,14Z-17Z)-eicosapentaenoate
|
SUBMITTER
|
(12S)-hydroperoxy-(5Z,8Z,10E,14Z-17Z)-icosapentaenoate
|
ChEBI
|
(5Z,8Z,10E,12S,14Z-17Z)-12-hydroperoxyicosapentaenoate
|
ChEBI
|
22984144
|
PubMed citation
|
SUBMITTER
|
|